2012
DOI: 10.1634/theoncologist.2012-s1-04
|View full text |Cite
|
Sign up to set email alerts
|

Is Radical Prostatectomy a Useful Therapeutic Option for High-Risk Prostate Cancer in Older Men?

Abstract: Prostate cancer affects a high proportion of men over 70 years of age, who are likely to have high-risk disease and a substantial risk of prostate-cancer-specific death. With life expectancy increasing worldwide, the burden of prostate cancer is also expected to rise. Thus, effective management of this high-risk senior patient group is increasingly important. Radical prostatectomy can increase survival and decrease the risk of metastatic progression. Postsurgery complications are affected more by comorbidity t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 31 publications
0
4
0
Order By: Relevance
“…It is well recognised that surgery can have a significant impact on catabolism and oxygen demand, and the length and extent of surgery is directly related to the risk of developing post-surgery complications [7]. Eligibility for radical prostatectomy is often based on chronological age, but evidence shows that post-surgery complications are affected more by comorbidities than age [8]. In clinical trials, even if there is no age limit, people are required to be “fit for treatment” as drug tolerance may decrease and toxicity may increase in those with poor fitness [9].…”
Section: Introductionmentioning
confidence: 99%
“…It is well recognised that surgery can have a significant impact on catabolism and oxygen demand, and the length and extent of surgery is directly related to the risk of developing post-surgery complications [7]. Eligibility for radical prostatectomy is often based on chronological age, but evidence shows that post-surgery complications are affected more by comorbidities than age [8]. In clinical trials, even if there is no age limit, people are required to be “fit for treatment” as drug tolerance may decrease and toxicity may increase in those with poor fitness [9].…”
Section: Introductionmentioning
confidence: 99%
“…This phenomenon of misclassification likely explains findings of previous studies that reported rather higher rates of biochemical recurrence or even metastatic progression in senior men (5)(6)(7), since the studies adjusted for clinical parameters. In fact, such contradicting findings in combination with a rather dated concept to derive life expectancy based on demographics instead at the individual level supported the widely adopted notion to refrain from offering surgical local treatment to senior patients with PCa since the beneficiary potential of RARP appeared compromised (3,(8)(9)(10)(11). Alternatively, these patients will be offered radiotherapy or administration of an androgen deprivation therapy (12), both options potentially associated with high morbidity and comparably ineffective treatment of possible Pre-existing urinary tract symptoms (13).…”
Section: Introductionmentioning
confidence: 99%
“…African-American men are nearly 1.6 times more likely to be diagnosed with prostate cancer than white men and almost 2.5 times more likely to die from the disease [ 2 ], exhibiting the highest rates of prostate cancer incidence and mortality in the USA [ 1 , 2 ]. Radical prostatectomy (RP) provides effective control for prostate cancer resulting in high survival rates subsequently increasing the number of survivors across races [ 4 ]. Long-term complications like urinary incontinence and sexual dysfunction are a burden for many men after surgery, and African-American men have reported higher rates of urinary, bowel, and physical issues than Caucasian men [ 3 , 5 , 6 ].…”
Section: Introductionmentioning
confidence: 99%